Sven Epple
Originally from the south of Germany, Sven obtained his Master of Science in Life Science from the University of Konstanz. During his studies, Sven conducted a 3-month internship at the King Mongkut’s University of Technology Thonburi in Bangkok, Thailand, in the field of medicinal chemistry. For his master’s project, Sven spent 6 months in Prof. Gunda I. Georg’s laboratory at the University of Minnesota, USA, researching novel bromodomain inhibitors for male contraception. His academic interests are organic synthesis, drug design/development and chemical biology. Currently, Sven is investigating oligonucleotides with different backbone modifications for various applications in therapeutics and diagnostics. When not working, Sven likes to go swimming or running.
4 Papers
Consecutive 5'- and 3'-amide linkages stabilise antisense oligonucleotides and elicit an efficient RNase H response
5496-5499, 2020.
Chemical Communications 56,Artificial nucleic acid backbones and their applications in therapeutics, synthetic biology and biotechnology
(5), 691-697, 2021.
Energing topics in life science 5A New 1,5-Disubstituted Triazole DNA Backbone Mimic with Enhanced Polymerase Compatibility
(39), 16293-16301, 2021.
Journal of the American Chemical Society 143An LNA-amide modification that enhances the cell uptake and activity of phosphorothioate exon-skipping oligonucleotides
(1), 1-11, 2022.
Nature Communications 13